RCA Telegram News California - News from San Francisco, California, the USA and the world, around the clock every day

Arvana Inc. Updates Corporate Information
RF Industries to Report Second Quarter Results on June 15
RF Industries to Report Second Quarter Results on June 15

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced that it will release its second quarter fiscal year 2026 financial results after the close of the market on Monday, June 15, 2026.

June 01, 2026

RECENT NEWS

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure

June 01, 2026

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurrence or death and a 59% reduction in the risk of distant metastasis or death compared to KEYTRUDA aloneIntismeran autogene in combination with KEYTRUDA demonstrated an encouraging trend toward overall survival in an exploratory analysis compared to KEYTRUDA alone (HR=0.471; [95% CI, 0.165-1.345])

June 01, 2026

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Rivaroxaban tablets of 2.5mg, 10mg, 15mg and 20mg for the Canadian market. Rivaroxaban is the generic equivalent of the brand name anticoagulant, Xarelto®.

June 01, 2026

RECENT NEWS

Eskay Mining Corp. announces First Targets in its 5,000 meter Drill Program on its Corey-Eskay Property in British Columbia's Golden Triangle
Eskay Mining Corp. announces First Targets in its 5,000 meter Drill Program on its Corey-Eskay Property in British Columbia's Golden Triangle

TORONTO, ON / ACCESS Newswire / June 1, 2026 / Eskay Mining Corp. ("Eskay" or the "Company") (TSXV:ESK)(OTC PINK:ESKYF)(Frankfurt:KN7)(WKN:A0YDPM) is pleased to announce details of its 5,000 meter diamond drilling program scheduled to commence in July 2026.

June 01, 2026

RECENT NEWS

Aclara Receives Favourable Consolidated Evaluation Report to the Penco Module Environmental Assessment Process
Aclara Receives Favourable Consolidated Evaluation Report to the Penco Module Environmental Assessment Process

TORONTO, ON / ACCESS Newswire / June 1, 2026 / Aclara Resources ("Aclara" or the "Company") (TSX:ARA) is pleased to announce that the Penco Module ionic clay project (the "Penco Module" or the "Project"), being developed in partnership with Grupo CAP in Chile, has received a Consolidated Evaluation Report from Chile's Environmental Assessment Service ("SEA") of the Biobío Region, recommending approval of the Project's Environmental Impact Assessment ("EIA").

June 01, 2026